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The linear, double-stranded DNA genome of vaccinia virus contains covalently closed hairpin termini. These
hairpin termini comprise a terminal loop and an AT-rich duplex stem that has 12 extrahelical bases. DeMasi
et al. have shown previously that proteins present in infected cells and in virions form distinct complexes with
the telomeric hairpins and that these interactions require the extrahelical bases. The vaccinia virus I6 protein
was identified as the protein showing the greatest specificity and affinity for interaction with the viral hairpins
(J. DeMasi, S. Du, D. Lennon, and P. Traktman, J. Virol. 75:10090-10105, 2001). To gain insight into the role
of I6 in vivo, we generated eight recombinant viruses bearing altered alleles of I6 in which clusters of charged
amino acids were changed to alanine residues. One allele (temperature-sensitive I6-12 [tsI6-12]) conferred a
tight ts phenotype and was used to examine the stage(s) of the viral life cycle that was affected at the
nonpermissive temperature. Gene expression, DNA replication, and genome resolution proceeded normally in
this mutant. However, proteolytic processing of structural proteins, which accompanies virus maturation, was
incomplete. Electron microscopic studies confirmed a severe block in morphogenesis in which immature, but
no mature, virions were observed. Instead, aberrant spherical virions and large crystalloids were seen. When
purified, these aberrant virions were found to have normal protein content but to be devoid of viral DNA. We
propose that the binding of I6 to viral telomeres directs genome encapsidation into the virus particle.
Vaccinia virus, the prototypic member of the Poxvirus family,
contains a 192-kb double-stranded DNA genome encoding
approximately 200 proteins involved in DNA replication, gene
expression, morphogenesis, and virus-host interaction (re-
viewed in reference 27). The genome is a linear duplex with
covalently closed hairpin termini. These termini exist in two
104-nucleotide (nt) isoforms (termed flip and flop) which are
inverted complements of one another (2, 3). The hairpin com-
prises a 4-nt terminal loop and a 44-bp highly AT-rich duplex
stem with 12 extrahelical bases, 10 on one strand and 2 on the
other. Extrahelical bases in the termini are maintained during
the viral life cycle in all poxviruses, although the positions and
numbers of extrahelical bases differ.
We have hypothesized that the viral telomeres play a role in
DNA replication. The current replication model proposes that
a nick proximal to the terminus is introduced, exposing a 3
hydroxyl group that serves as the primer terminus for the
initiation of DNA synthesis (reviewed in reference 35). Evi-
dence supporting this model was obtained by labeling synchro-
nized infections with [3H]thymidine; radiolabel was first incor-
porated within 200 bp of the telomere region (30, 31).
Additional evidence was provided by studies in our laboratory
that used a minichromosome replication assay (8). Minichro-
mosomes contain a plasmid-derived stuffer sequence flanked
by viral telomeric sequences of various lengths. When
minichromosomes were introduced into infected cells by trans-
fection, the minimal telomeric region necessary and sufficient
for efficient replication of the minichromosome comprised 150
to 200 bp. This region includes the 104-nt hairpin and an
additional 87 bp of a unique sequence, which encompasses but
extends beyond the sequence elements required for resolution
of concatemeric replication intermediates.
Given the importance of telomeres in viral replication, a
considerable effort was made to identify proteins that might
interact with the telomeres while promoting the initiation of
DNA replication. Using electrophoretic mobility shift assays,
we demonstrated that each isoform of the telomeric hairpin
was able to form two distinct complexes with proteins present
in virions and infected cells (6). These interactions required
the extrahelical bases that are so characteristic of the viral
hairpins. Using biotinylated hairpins immobilized on strepta-
vidin-conjugated magnetic beads, our laboratory purified and
identified the I1 and I6 proteins as those responsible for form-
ing these complexes.
Fortuitously, our laboratory had previously studied the I1
protein, showing it to be expressed during late times of infec-
tion and encapsidated in the virion core (21). Purified recom-
binant I1 protein possesses promiscuous DNA-binding activity
but prefers viral hairpins as a substrate. Repression of I1 (en-
abled by the construction of an IPTG [isopropyl--D-thioga-
lactopyranoside]-inducible recombinant virus) resulted in a
specific and tight arrest in viral morphogenesis. Viral assembly
appeared to progress normally through the formation of im-
mature virions with nucleoids (IVN), but no further matura-
tion into infectious, mature virions was seen.
In contrast to I1, no studies analyzing the structure or func-
tion of the I6 protein have been published to date. The mo-
lecular mass of I6 is predicted to be 43.5 kDa, and apart from
counterparts in other poxviruses, no significant homology to
any other proteins was found by computer analysis. Our labo-
ratory confirmed that recombinant I6 protein specifically rec-
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ognizes extrahelical bases and binds to the viral hairpins with
great specificity and stability (6). The work described herein
was designed to elucidate the role of I6 in vivo. We describe
the generation of eight recombinant viruses bearing altered
alleles of I6 and demonstrate that one of these alleles (I6-12)
confers a tight ts phenotype. Analysis of the conditionally le-
thal phenotype of this virus has uncovered a key role for the I6
telomere-binding protein, and by extrapolation, for the viral
telomeres, in the poorly understood process of DNA encapsi-
dation.
MATERIALS AND METHODS
Materials. Restriction endonucleases, Taq DNA polymerase, T4 DNA ligase,
calf intestinal alkaline phosphatase, pancreatic RNase, Escherichia coli DNA
polymerase I, DNase I, and DNA molecular weight standards were purchased
from either Roche Molecular Biochemicals (Indianapolis, Ind.) or New England
Biolabs (Beverly, Mass.). [35S]Met and 32P-labeled nucleoside triphosphates
were purchased from PerkinElmer Life Sciences (Boston, Mass.). Lipofectamine
Plus, geneticin (G418 sulfate), and 14C-labeled protein molecular weight markers
were purchased from Invitrogen (Carlsbad, Calif.). Rifampin (RIF) and 1--D-
arabinofuranosylcytosine (araC) were obtained from Sigma (St. Louis, Mo.).
Isatin--thiosemicarbazone (IBT) was obtained from Pfaltz and Bauer (Water-
bury, Conn.). Oligonucleotides were purchased from IDT (Coralville, Iowa).
Cells and viruses. BSC40 African green monkey kidney cells were maintained
as monolayer cultures in Dulbecco modified Eagle medium (DMEM) (Invitro-
gen) containing 5% fetal bovine serum (FBS). Stocks of wild-type (wt) vaccinia
virus (WR strain) and the viruses described herein, which contained mutant
alleles of the I6 gene, were prepared by ultracentrifugation of cytoplasmic ex-
tracts through a 36% sucrose cushion.
Site-directed mutagenesis and cloning of the I6 gene into pUC/Neo. Eight
regions of the I6 gene were chosen for clustered charge-to-alanine mutagenesis
(Fig. 1) (7, 32). Mutations were generated by overlap PCR using the HindIII I
fragment of the vaccinia virus genome as the template. In the first round of PCR,
one reaction was performed using an upstream primer (U) and a downstream
primer carrying the engineered nucleotide substitutions (#mut-3); a second
reaction was performed using an upstream primer carrying the desired substitu-
tions (#mut-5) and a downstream primer (D). The two PCR products from this
first round of amplification overlapped by 17 bp. A mixture of the two products
served as the template for a second round of PCR performed with primers U and
D. The final PCR product contained the desired mutations flanked by 300 bp of
upstream and downstream sequences. Primers U and D introduced BamHI
recognition sites at the termini of the amplified fragments. The final PCR
products were gel purified, digested with BamHI, and cloned into pUC/Neo
DNA that had been previously digested with BamH1 and treated with calf
intestinal alkaline phosphatase. This plasmid carries the neomycin resistance
gene (Neo) under the control of the constitutive viral p7.5 promoter (21, 24). The
constructs were subjected to automated DNA sequencing to ensure the presence
of the desired nucleotide substitutions and the absence of any additional muta-
tions. The primers used are listed in Table 1.
Transient dominant selection and isolation of I6 recombinant viruses. Tran-
sient dominant selection was used to replace the endogenous I6 gene with the
mutant allele (10, 21, 24, 32). Dishes (35-mm diameter) of BCS40 cells were
infected with wt virus at a multiplicity of infection (MOI) of 0.03 PFU/cell at
37°C. At 3 h postinfection (hpi), 3.5 g of the desired pUC/Neo-I6 plasmid was
introduced into cells by transfection using Lipofectamine Plus reagent (Invitro-
gen) and cells were transferred to 32°C. 32°C was utilized for all subsequent steps
in the generation of the recombinant viruses. At 16 hpi, geneticin (G418 sulfate)
was added to a final concentration of 3 mg per ml to select for the spread and
replication of virus that had incorporated the plasmid into the genome. Cells
were harvested 2 days after infection, and virus was released by three cycles of
freezing and thawing and two 15-s bursts of sonication. After two rounds of
plaque purification in the presence of geneticin, incorporation of the plasmid
into the drug-resistant viral isolates was confirmed by PCR using primers specific
for the Neo gene. These “parental” viruses have the entire plasmid incorporated
into the I6 locus and therefore have tandem repeats of a portion of the I5, I6, and
I7 regions flanking the Neor gene. Drug selection was then removed, and several
rounds of plaque purification were performed to enable recombination to occur
within these repeats. Such recombination leads to the loss of the Neor gene and
the retention of either the wt or mutant allele of I6. The loss of the Neor gene
was monitored by PCR. The I6 allele was amplified by PCR from those viruses
shown to have undergone recombinational resolution, and automated DNA
sequence analysis was used to distinguish viruses carrying the desired mutant I6
alleles from wt isolates. The appropriate plaques were expanded, and purified
viral stocks (designated vI6-1, vI6-2, vI6-4, vI6-5, vI6-6, vI6-9, vI6-12, and vI6-13)
were prepared by ultracentrifugation of cytoplasmic extracts through a 36%
sucrose cushion.
Determination of 24-h viral yields. Dishes (35-mm-diameter) of confluent
BSC40 cells were infected at an MOI of 2 with wt or vI6 viruses and incubated
at either 32 or 40°C. At 24 hpi, cells were harvested by scraping, collected by
centrifugation, resuspended in phosphate-buffered saline (PBS) (140 mM NaCl,
2 mM KCl, 10 mM Na2HPO4, 1 mM KH2PO4 [pH 7.4]), and disrupted by three
FIG. 1. Clustered charge-to-alanine mutagenesis of the vaccinia
virus I6L gene. The predicted amino acid sequence of the I6 protein of
the WR strain is shown. A total of 13 clusters of charged residues were
found (underlined); eight of these regions (numbered) were selected
for mutagenesis. For each of the mutant alleles, the codons encoding
the charged residues (shaded in gray) were mutated to encode alanine.
Viruses in which the endogenous I6 gene was replaced with the indi-
vidual mutant alleles were obtained by transient dominant selection.
TABLE 1. Primers used in the studya





U (1, 2, 4) 5 CAGGATCCAGCTGTTGGAATCTGA D (1, 2, 4) 5 CGGGATCCGGTAGTCTCTCTTTCG
U (5, 6) 5 CAGGATCCGATGGACTGTTTACTA D (5, 6) 5 CGGGATCCTATAGATACCCTTCC AG
U (9, 12, 13) 5 CAGGATCCTTTCCCATTCGATACAG D (9, 12, 13) 5 CGGGATCCATTTGACGTATGTAGCG
#1–5 5 TAGCACCTACCGCAGCATTGTCTCCGTCAGATG #1–3 5 TGCTGCGGTAGGTGCTAGAGACTTTGAAGCTA
#2–5 5 GGCGGCTGTTCTTGCATCACTCTTGATCATG #2–3 5 ATGCAAGAACAGCCGCCGGAGTATTAATGGGC
#4–5 5 CGTCGCCGCTGCTCCTGAAACACACGTGG #4–3 5 CAGGAGCAGCGGCGACGCCCGTCAACCAA
#5–5 5 CACAGCAGCAGCATTAAGTATTAATACGTT #5–3 5 TTAATGCTGCTGCTGTGGTAAGTACCGAT
#6–5 5 GTCCGGCAGCGGCACTACCGTATATCATCG #6–3 5 GTAGTGCCGCTGCCGGACTTATATAGCTTA
#9–5 5 ATAATGCGGCTCTAAACACAATCTTGG #9–3 5 GTTTAGAGCCGCATTATTAATATGAGTAA
#12–5 5 CTAATGCGGCAGCAATATGTAAGA AACATTG #12–3 5 CATATTGCTGCCGCATTAGTAACTGACTTAA
#13–5 5 TATGTGCGGCACATTGTTTCGTCAATTC #13–3 5 ACAATGTGCCGCACATATTTTTTTCTTAT
a BamHI sites are underlined; the mutated nucleotides are shown in boldface characters.
b For the U and D primers, the numbers in parentheses designate the alleles for which each primer was used.
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cycles of freezing and thawing and two 15-s bursts of sonication. Viral yields were
determined by plaque assays performed at 32°C on BSC40 monolayers.
Marker rescue. Dishes (35-mm-diameter) of BSC40 cells were infected with
tsI6-12 at an MOI of 0.006 and incubated at 32°C. At 3 hpi, 5 g of linearized
plasmid DNA was introduced into cells with Lipofectamine Plus reagent. Plas-
mids contained no insert, the wt I6 open reading frame (ORF), the genomic
HindIII I fragment, or the genomic HindIII G fragment (negative control). At 6
hpi, dishes were fed with fresh DMEM–5%FBS and transferred to 40°C. At 2
dpi, cells were harvested and the yield of temperature-insensitive virus was
determined by titration at 40°C.
Analysis of viral protein synthesis. Confluent BSC40 cells were infected with
wt virus or tsI6-12 at an MOI of 10 and incubated at 32 or 40°C. At the
appropriate times, cells were rinsed with prewarmed methionine-free DMEM,
incubated for 45 min in the same medium supplemented with 100 Ci of
[35S]Met/ml, and then harvested. Cells were harvested at 2, 3.5, 5, 6.5, and 8 hpi;
the proteins within whole-cell lysates were resolved by electrophoresis on a
sodium dodecyl sulfate (SDS)–12% polyacrylamide gel and then visualized by
autoradiography.
Analysis of the proteolytic processing of viral structural proteins. Cells were
infected with wt virus or tsI6-12 at an MOI of 5 in the presence or absence of RIF
(100 g/ml) and incubated at 32 or 40°C. At 8 hpi, cells were labeled as described
above for 45 min; samples were either harvested immediately (pulse) or rinsed
and fed with prewarmed DMEM–5%FBS and harvested at 24 hpi (chase).
Analysis of viral DNA synthesis by Southern dot blot hybridization. Dishes
(35-mm-diameter) of confluent BSC40 cells were infected with wt virus or tsI6-12
at an MOI of 5 and incubated at 32 or 40°C. At 3, 6, 9, 12, and 24 hpi, cultures
were harvested and analyzed in duplicate by dot blot DNA hybridization as
previously described (32). Viral DNA was detected by hybridization with a
radiolabeled probe representing the HindIII E and HindIII G fragments of the
vaccinia virus genome. Data were quantitated by phosphorimager analysis and
plotted using Sigma Plot software.
Genome resolution assay. Cells were infected with wt virus or tsI6-12 at an
MOI of 2 and incubated at 32 or 40°C. As controls, cells were also infected with
wt virus (MOI of 2) in the presence of 60 M IBT or with vROG8 virus (a
recombinant in which expression of the G8 gene is dependent upon inclusion of
IPTG in the culture medium) (41) at an MOI of 15. At 18 hpi, cells were
harvested and cytoplasmic DNA was prepared, digested with BstEII, and re-
solved on a Tris-acetate-EDTA–agarose gel. The DNA was transferred to a
ZetaProbe membrane, and Southern blot hybridization was performed using a
radiolabeled probe representing a 1.2-kb PvuII-EcoRI fragment released from
the pSV9 plasmid (25, 26). This probe hybridizes to the genomic telomeres and
adjacent sequences. The blot was then visualized by autoradiography.
Electron microscopy. Dishes (60-mm-diameter) of BSC40 cells were infected
with tsI6-12 virus at an MOI of 2 and incubated at 32 or 40°C. At 17 hpi, cells
were rinsed with PBS and fixed in situ with 1% glutaraldehyde–0.1 M PBS (pH
7.4) on ice for 30 min. Cells were scraped gently, collected by centrifugation (800
 g for 10 min), and then processed for conventional electron microscopy as
described previously (7, 36). Purified viral particles were concentrated by sedi-
mentation (13,000  g for 5 min) and then processed as described above.
Samples were examined on a Hitachi H-600 transmission electron microscope.
Purification of virus particles. Four 15-cm-diameter dishes of BSC40 cells
were infected with either wt virus or tsI6-12 at an MOI of 2 and kept at 32 or
40°C. At 24 hpi, cells were harvested and disrupted by Dounce homogenization.
Virus particles were purified from cytoplasmic extracts by ultracentrifugation
through a 36% sucrose cushion (43,000  g for 80 min) followed by banding on
a 25 to 40% sucrose gradient (6,000  g for 45 min). After the gradients were
photographed, 20 fractions (250 l each) were collected beginning at the bottom
of the tube. Aliquots from each fraction were solubilized with 0.25% NP-40–
0.25% deoxycholate–250 mM NaCl–0.5 mM dithiothreitol, and the protein con-
tent was quantitated by a Bradford assay (Bio-Rad, Hercules, Calif.). Fractions
containing detectable amounts of protein which corresponded to those contain-
ing a light-scattering band were analyzed by SDS-polyacrylamide gel electro-
phoresis (PAGE) and silver staining.
Immunoblot analysis. Protein samples were resolved by SDS-PAGE and elec-
trophoretically transferred to nitrocellulose membranes in CAPS [3-(cyclohexy-
lamino)-1-propanesulfonic acid] buffer (10 mM CAPS [pH 11.3], 10% metha-
nol). Membranes were incubated with sera generated in our laboratory which
react with the L4, F18, and I1 proteins (21, 24) or with sera directed against the
I7 and L1 proteins, which were generous gifts from S. Shuman (Sloan-Kettering
Institute, New York, N.Y.) and D. Hruby (Oregon State University, Corvallis,
Oreg.), respectively. Horseradish-peroxidase-conjugated goat anti-rabbit second-
ary antibody was used, and immunoreactive proteins were visualized after chemi-
luminescent development.
Southern dot blot analysis of purified viral particles. Fractions 7 to 18 (5 l
each) from the 25 to 40% sucrose gradient (see above) were diluted in 50 l of
water, boiled for 5 min, and applied (using a Bio-Dot microfiltration apparatus
[Bio-Rad]) to a hydrated ZetaProbe membrane (Bio-Rad). Samples were dena-
tured and renatured in situ, and the blot was then subjected to Southern dot blot
hybridization using 106 cpm of radiolabeled probe/ml representing the vaccinia
virus HindIII E and HindIII F genomic fragments. Data were analyzed on a
phosphorimager.
Computer analysis. Autoradiographic films and electron micrographic nega-
tives were scanned using a SAPHIR scanner (Linotype-Hell Co., Hauppauge,
N.Y.). Plaque assays were photographed using an AlphaImager (Alpha Innotech,
San Leandro, Calif.) documentation system. Data for the Southern dot blot
analyses were acquired using a Storm PhosphorImager (Molecular Dynamics,
Sunnydale, Calif.) and quantitated using ImageQuant software (Molecular Dy-
namics). Images were adjusted with Adobe Photoshop 5.0 software (Adobe
Systems Inc., San Jose, Calif.), data were plotted using SigmaPlot 7.1 software
(SSPS, Chicago, Ill.), and final figures were assembled and labeled with Canvas
8.0 software (Deneba Systems, Miami, Fla.).
RESULTS
We implemented a genetic analysis of the telomere-binding
I6 protein to study its function in vivo. Clustered charge-to-
alanine mutagenesis was used to generate several altered al-
leles of I6 that might engender a ts phenotype within the
context of viral infection. This technique has been successfully
used in our laboratory and others to generate viruses with
conditionally lethal mutations in such viral genes as H5, A20,
and D1 (7, 15, 16, 18, 32). Clusters of charged amino acids are
thought to have a high likelihood of lying on the surface of a
protein and are therefore likely to serve as interaction sites
with other molecules. When these residues are changed to
alanine, these interactions may weaken, with the decrement of
function being temperature dependent (38). If the stability
and/or activity of the protein were essential for virus viability,
such a mutation would thus cause a conditional lethality that
would manifest itself at 40 but not at 32°C, the temperatures
chosen for experimental use.
Replacement of the endogenous I6 allele with alleles carry-
ing clustered charge-to-alanine substitutions. A total of 13
clusters of charged residues were identified in the predicted
amino acid sequence of the I6 protein (Fig. 1). Of these, eight
clusters spread throughout the I6 ORF were chosen for alter-
ation. Overlap PCR was used to change the codons for these
residues (shaded) in regions 1, 2, 4, 5, 6, 9, 12, and 13 so that
they would instead encode alanine. Mutant alleles were then
inserted into the pUC/Neo plasmid, which contains the neo-
mycin resistance gene (Neor) under the control of a constitu-
tive vaccinia virus promoter (24), to facilitate their placement
within the endogenous I6 locus of the viral genome.
Allelic replacement of the endogenous (wt) I6 gene was
accomplished with the use of transient dominant selection (10,
21, 24). pUC/Neo plasmids containing the mutant I6 alleles
were introduced into cells infected with wt virus, and following
infection-transfection, the cells were maintained at 32°C in the
presence of G418 for 2 days. Viruses that had incorporated the
plasmid into their genomes via homologous recombination
were selected by two rounds of plaque purification performed
in the presence of G418. Insertion of the plasmid was con-
firmed by screening viral isolates for the presence of the Neor
gene by PCR. These G418r viruses contain an unstable, tan-
dem duplication of the I6 region flanking the Neor gene. When
selective pressure is removed by performing additional rounds
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of plaque purification in the absence of G418, the duplicated
sequences readily undergo homologous recombination, result-
ing in the loss of the Neor gene. This resolution reaction was
monitored by PCR; viruses in which the resolved genome re-
tained the mutant, rather than the wt, I6 allele were identified
by DNA sequence analysis. All eight recombinant viruses,
vI6-1, vI6-2, vI6-4, vI6-5, vI6-6, vI6-9, vI6-12, and vI6-13, were
successfully isolated at 32°C. Thus, each of the alleles gener-
ated could support virus viability at this permissive tempera-
ture.
Phenotypic analysis: several I6 alleles affect plaque size
and/or viral yield. The eight viruses generated were tested for
their ability to form plaques at 32 and 40°C (Fig. 2). All mutant
viruses were able to form plaques at 32°C, although the
plaques observed for vI6-1, vI6-2, and vI6-13 were somewhat
smaller than those formed by wt virus. The viruses showed
FIG. 2. Comparison of the plaque-forming abilities of wt virus and the vI6 viruses at 32 and 40°C. Confluent monolayers of BSC40 cells were
infected with 150 PFU of virus for 48 h at the indicated temperature and then fixed and stained with crystal violet. All the mutant viruses formed
plaques at both 32 and 40°C. At 32°C, viruses carrying alleles 1, 2, and 13 formed somewhat smaller plaques than did wt virus. At 40°C, viruses
carrying alleles 1, 2, 12, and 13 formed significantly smaller plaques than did wt virus.
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distinct differences at 40°C. vI6-4, vI6-5, vI6-6, and vI6-9
formed large plaques comparable in size to those formed by wt
virus, whereas vI6-1, vI6-2, vI6-12, and vI6-13 formed smaller
plaques. This temperature-dependent decrease in plaque size
might reflect a reduction in infectious viral yield during the first
and subsequent rounds of infection or might instead reflect a
decrease in the ability of the mutant virus to spread to adjacent
cells after the first round of infection.
To quantitate the total yield of infectious virus from a single
round of infection, BSC40 cells were infected with wt or mu-
tant viruses at an MOI of 2 and maintained at 32 or 40°C for
24 h. As shown in Fig. 3A, wt infections produced similar
amounts of infectious virus at both temperatures; similar re-
sults were obtained for vI6-4, vI6-5, vI6-6, and vI6-9. vI6-1,
vI6-2, vI6-12, and vI6-13 were ts. For vI6-1, vI6-2, and vI6-13,
the viral yield at 32°C was 6- to 8-fold lower than that obtained
from wt infections performed in parallel and 30- to 40-fold
lower than that obtained from wt infections at 40°C. vI6-12
exhibited the tightest ts phenotype; the yield at 32°C was com-
parable to that obtained with wt virus, whereas a 100-fold
reduction in viral yield was seen at 40°C, the nonpermissive
temperature. This virus, denoted as tsI6-12, was chosen for
further characterization, as described below.
Surprisingly, tsI6-12, which shows a 2-log reduction in 24-h
viral yield at 40°C, was still able to form small plaques at this
temperature. We therefore monitored the time course of virus
production in cells infected with tsI6-12 to more clearly distin-
guish between reduced and delayed virus production (Fig. 3B).
In wt-infected cells, virus production was more rapid at 40 than
at 32°C but reached an equivalent plateau at 24 hpi. A similar
growth curve was observed for the tsI6-12 infection performed
at 32°C, although the viral yield was slightly lower than that
obtained for wt virus at 32°C. In contrast, cells infected non-
permissively with tsI6-12 showed an increase in viral yield from
8 to 16 hpi, after which no further virus production was seen.
This result demonstrates that the production of infectious virus
during a nonpermissive tsI6-12 infection is blocked rather than
delayed.
Marker rescue was performed to confirm that the ts pheno-
type of tsI6-12 was indeed caused by the engineered mutation
and was not due to an unintended, nonfortuitous change in the
genome of this virus. Cells were infected at 40°C with tsI6-12
and transfected with linearized plasmid DNA with or without
a wt I6 ORF insert; at 48 hpi, the yield of temperature-insen-
sitive virus was titrated at 40°C. Plasmid DNA containing the
wt I6 gene, but not empty plasmid, resulted in a significantly
increased yield of virus able to form large plaques at 40°C (data
not shown), verifying that the ts phenotype was caused solely
by the amino acid substitutions within the I6 gene.
Neither viral DNA synthesis nor concatemer resolution is
defective in nonpermissive tsI6-12 infections. Given the affinity
of the I6 protein for the viral telomeric hairpins and the im-
portance of these structures for minichromosome replication,
we hypothesized that I6 might play a role in DNA replication.
To examine this possibility, we quantitated the accumulation of
viral DNA in cells infected with wt virus or tsI6-12 at 32 or
40°C. Cell lysates were prepared at 3, 6, 9, 12, and 24 hpi and
analyzed by Southern dot blot analysis. As shown in Fig. 4A,
the profiles of DNA accumulation were comparable in all of
the samples, indicating that the tsI6-12 allele does not cause a
ts defect in viral DNA synthesis. We also examined the tem-
poral profile of viral protein synthesis in cells infected with wt
virus or tsI6-12 at both 32 and 40°C. Lysates were prepared
from cultures metabolically labeled with 35S-Met at various
times postinfection, resolved by SDS-PAGE, and visualized by
autoradiography; the patterns of protein expression directed
FIG. 3. Comparison of virus production levels during synchronous
infections with wt virus and the vI6 mutants at 32 and 40°C. (A) Quan-
titation of 24-h infectious viral yield: alleles 1, 2, 12, and 13 affected
virus production, with allele 12 causing a tight ts phenotype. Confluent
monolayers of BSC40 cells were infected with wt virus or vI6 viruses
(MOI of 2) and incubated at 32 or 40°C. At 24 hpi, cells were harvested
and disrupted and the yield of cell-associated, infectious virus was
measured by plaque assay at 32°C. (B) Time course of virus production
in tsI6-12-infected cultures: virus production was diminished, not de-
layed. Confluent monolayers of BCS40 cells were infected with wt virus
or tsI6-12 (MOI of 2), incubated at 32 or 40°C, and harvested at 8, 16,
24, 32, or 44 hpi. Cells were disrupted, and the viral yield was measured
by plaque assay at 32°C.
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by the two viruses were indistinguishable (data not shown).
Because DNA synthesis is a prerequisite for the switch to
intermediate and late transcription, these data confirm that the
tsI6-12 allele does not affect the progression of DNA replica-
tion and also indicate that it has no impact on viral gene
expression.
Next, we asked whether viral replication intermediates (con-
catemers) were efficiently resolved into monomeric genomes.
Viral DNA was extracted from cells infected with wt or tsI6-12
virus at 32 or 40°C and analyzed by Southern blot hybridization
using a probe that differentiates between concatemeric and
monomeric genomes. As controls, cells were infected under
conditions that compromised late gene expression and hence
led to diminished concatemer resolution. These conditions are
engendered by infection with wt virus in the presence of the
drug IBT or with vROG, a recombinant virus in which the
late-transcription factor G8 is repressed when IPTG is omitted
from the culture medium (29, 41). As shown in Fig. 4B, the
samples prepared from cells infected with vROG (lane 1) or
with wt virus in the presence of IBT (lane 2) both accumulated
unresolved concatemers (2.6-kb BstII band) whereas mono-
mers (1.3-kb predicted band) predominated in the samples
prepared from wt and tsI6-12 infections performed at either 32
or 40°C (lanes 3 to 6). We conclude that genome resolution
proceeds normally during nonpermissive infections performed
with tsI6-12.
Proteolytic processing of late viral core proteins is incom-
plete in tsI6-12. The data described above indicate that the
replication cycle of tsI6-12 proceeds normally through the bio-
chemical processes of viral gene expression, DNA replication,
and genome resolution. Therefore, the defect must lie in a
subsequent stage of the viral life cycle—affecting either virion
morphogenesis or virion infectivity. As an initial test of
whether morphogenesis might be affected, we examined the
proteolytic processing of the major core proteins. Three abun-
dant viral structural proteins (p4a, p4b, and preL4) are pro-
teolytically cleaved in a manner that is tightly linked to intra-
cellular mature virus (IMV) formation (37). Cells were
infected with wt virus or tsI6-12 at 32 or 40°C; as a control, cells
were also infected with wt virus in the presence of RIF, a drug
that inhibits viral morphogenesis (14, 28). At 8 hpi, cells were
pulsed with [35S]-Met for 45 min; half of the cultures were
harvested immediately (Fig. 5, lanes p) and the other half were
rinsed and fed with medium containing unlabeled methionine
and incubated for an additional 16 h (lanes c). During wt
infection, cleavage of the three viral precursors into the prod-
ucts 4a, 4b, and L4 was nearly complete at both temperatures
(compare lanes 3 and 4 to lanes 5 and 6). In the presence of
RIF, however, only minimal cleavage is observed (compare
lanes 1 and 2). Processing is somewhat diminished in the
tsI6mut-12 infection performed at 32°C, as evidenced by the
persistence of detectable levels of uncleaved precursors in the
FIG. 4. DNA replication and concatemer resolution are not impaired
in nonpermissive tsI6-12 infections. (A) Cells were infected with wt virus
or tsI6-12 (MOI of 5) and incubated at 32 or 40°C. Cells were harvested
at 3, 6, 9, 12, or 24 hpi, and the levels of intracellular, viral DNA (ex-
pressed in arbitrary [arb.] units) were determined by Southern dot blot
hybridization (in duplicate) and quantitated by phosphorimager anal-
ysis. (B) Cells were infected with wt virus (lanes 3 and 4) or tsI6-12
(lanes 5 and 6) (MOI of 2) and incubated at 32°C (lanes 3 and 5) or
40°C (lanes 4 and 6). As controls, cells were infected with vROG8
(MOI of 15) in the absence of IPTG (lane 1) or with wt virus (MOI of
2) in the presence of 60 M IBT (lane 2) (conditions which lead to the
accumulation of unresolved concatemers). At 18 hpi, cells were har-
vested and cytoplasmic DNA was extracted and digested with BstEII.
DNA was resolved by electrophoresis, transferred to a ZetaProbe
membrane, and hybridized with a radiolabeled probe that anneals
to the termini of mature genomes (1.3-kb predicted fragment [filled
arrow]) and the junction fragment of unresolved concatemeric inter-
mediates (2.6-kb fragment [open arrow]). (The probe also hybridizes
to the BstEII fragment proximal to the telomeric regions E.) The
electrophoretic migration of DNA standards is shown at the left, with
sizes indicated in kilobases.
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sample harvested after the 16-h chase (compare lanes 7 and 8
to lanes 3 and 4). This diminution of processing is more pro-
nounced at 40°C, at which temperature only 30% of the
precursor is processed (compare lanes 9 and 10 to lanes 5 and
6). This observation implies that viral morphogenesis is com-
promised during nonpermissive tsI6-12 infections.
Morphogenesis is blocked at the IV-to-IMV transition dur-
ing nonpermissive tsI6-12 infections. Virus assembly proceeds
through several visually distinct stages: the appearance of elec-
tron-dense regions (termed virosomes) in the cytoplasm, the
formation of crescents at the virosomal periphery, the matu-
ration of these crescents into viroplasm-containing immature
virions (IV), the development of nucleoid-containing IVN, and
transformation into the infectious form known as IMV (re-
viewed in reference 27). Transmission electron microscopy was
used to investigate the progression of virion morphogenesis in
cells infected with tsI6-12. In cultures infected at the permis-
sive temperature, all of the typical hallmarks of morphogenesis
were observed (data not shown). We also noted the presence
of some additional, unusual structures (see below), which were
more dramatic and predominant in cells infected at the non-
permissive temperature. The images shown in Fig. 6 illustrate
the range of structures seen in cells infected with tsI6-12 at
40°C. Cells contained normal virosomes, crescents, and IV.
However, there was a virtual absence of IVN and IMV. A few
IV contained several dark internal foci but nothing comparable
to a nucleoid. In other IV, the internal electron-dense material
was distributed asymmetrically to one hemisphere. The most
abundant and distinct structures observed were spherical, elec-
tron-dense particles. Another unusual feature was the pres-
ence of large crystalloids, often surrounded by membrane.
Brick-shaped crystalloids (thought to represent viral DNA)
have been documented in infected cells treated with RIF, a
drug that arrests morphogenesis prior to IV formation (14).
The crystalloids seen here were several times larger than those
observed in the presence of RIF and also lacked a precise
rectangular shape; however, the internal structure of parallel
filaments was retained.
The execution point of the I6-12 allele occurs at late times of
infection. Temperature shift experiments represent classical
genetic tools for the determination of the execution point of
conditionally lethal mutants. To determine when the tsI6-12
allele exerts its effect during the infectious cycle in a manner
that causes an arrest in virus maturation, we performed a series
of shift-up and shift-down experiments. When infections were
initiated at 32°C and cultures were then shifted up to 40°C at
3, 6, or 9 hpi, the 24-h yield was approximately 2 logs lower
than that obtained from cells maintained at the permissive
temperature for the full 24 h (Fig. 7A). When cultures were
shifted to 40°C at 12 hpi, the 24-h yield was no higher than that
obtained from the 32°C cultures harvested at 12 hpi. Thus,
even when infections were maintained at the permissive tem-
perature for the first 12 h of infection, the shift to 40°C blocked
further production of virus. The execution point was therefore
very late in the infectious cycle, during the crucial stages of
virus assembly.
The converse experiment was also performed: infections
were initiated at 40°C and cultures were shifted down to 32°C
at various times postinfection (Fig. 7B). When infected cul-
tures were shifted down at 3 or 6 hpi, the viral yield was
equivalent to that obtained from fully permissive infections.
Even when cultures were shifted down at 9 or 12 hpi, only a
threefold decrease in viral yield was seen. These shift-down
experiments confirm that the function of the I6 protein is most
crucial at late times of infection.
We next asked whether the recovery of virus production
seen in cultures shifted down to 32°C in the midst of infection
depended on de novo morphogenesis and/or DNA synthesis.
When RIF was added to the cultures as they were shifted down
to the permissive temperature at 12 hpi, the viral yield was
reduced to the levels obtained from cultures maintained at
40°C (Fig. 7C). Since RIF blocks morphogenesis at crescent
formation prior to the block seen in tsI6-12 infections, we
conclude that the viral structures that accumulate during non-
permissive tsI6-12 infections are dead-end products and that
de novo morphogenesis is required to reverse the ts arrest. An
analogous experiment was performed using araC, an inhibitor
of DNA synthesis. Addition of araC to permissive infections at
12 hpi did not reduce the 24-h viral yield, indicating that the
pool of DNA synthesized prior to 12 h was sufficient to support
normal levels of virus production. However, when araC was
added to the 40°C cultures as they were shifted to the permis-
sive temperature at 12 hpi, the viral yield was reduced to the
FIG. 5. Proteolytic processing of viral structural proteins is im-
paired during nonpermissive tsI6-12 infections. Cells were infected
with wt virus (lanes 3 to 6) or tsI6-12 (lanes 7 to 10) (MOI of 10) and
incubated at 32°C (lanes 3, 4, 7, and 8) or 40°C (lanes 5, 6, 9, and 10).
As a control, cells were infected with wt virus in the presence of RIF
(100 g/ml) (lanes 1 and 2), which causes morphogenesis to arrest at
an early stage prior to the proteolytic processing of core proteins. At 8
hpi, cells were metabolically labeled with [35S]-Met for 45 min; cells
were then either harvested immediately (pulse [p] lanes [lanes 1, 3, 5,
7, and 9]) or refed with DMEM–5% FBS, returned to 32 or 40°C, and
harvested at 24 hpi (chase [c] lanes [lanes 2, 4, 6, 8, and 10]). Samples
were resolved by SDS-PAGE and visualized by autoradiography. Short
dashes indicate the precursor form of the virion core proteins (p4a,
p4b, and preL4); longer lines indicate the proteolytically processed
forms (4a, 4b, and L4). Protein standards are shown at the left; their
molecular masses are shown in kilodaltons.
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FIG. 6. During nonpermissive infections with tsI6-12, virion morphogenesis proceeds through IV formation but arrests prior to IMV formation.
BSC40 cells were infected with tsI6-12 (MOI of 2) and maintained at 40°C for 17 h. Cells were fixed in situ and processed for transmission electron
microscopy. Structures are indicated as follows: V, virosome; C, crescent;, IV with electron-dense foci; *, half-filled particle; , electron-dense
spherical particle;3, crystalloid. Note the absence of IVN and IMV. Final magnifications: (A) 9,000, (B) 25,000, (C) 30,000, (D) 45,000,










FIG. 7. The execution point of the tsI6-12 allele occurs late during infection (12 hpi). Confluent monolayers of BSC40 cells were infected with
tsI6-12 (MOI of 2) and harvested at 24 hpi unless otherwise indicated. Viral yield was measured by a plaque assay at 32°C. In each case, the
experimental strategy is depicted at the left, with the periods at 32°C shown with grey bars and periods at 40°C shown with hatched grey bars. The
data are shown at the right; all experiments were performed in triplicate and the average titers are shown (with error bars). (A) Shift-up
experiments. All infections were initiated at 32°C. Two cultures were maintained at the permissive temperature and harvested at 12 or 24 hpi. The
remaining cultures were shifted to the nonpermissive temperature at 3, 6, 9, or 12 hpi and then harvested at 24 hpi. (B) Shift-down experiments.
All infections were initiated at 40°C. One culture was maintained at 40°C for 24 h. The remaining cultures were shifted to the permissive
temperature at 3, 6, 9, or 12 hpi and then harvested at 24 hpi. (C) Reversal of the ts arrest by a shift to 32°C at 12 hpi requires de novo DNA
synthesis and virion morphogenesis. Confluent monolayers of BSC40 cells were infected at 32 or 40°C. At 12 hpi, araC (20 M) (diagonally hatched
bars without shading) or RIF (100 g/ml) (vertically hatched bars without shading) was added to the medium and cultures were shifted to or
maintained at 32°C. Data shown in panels A and B (e.g., the results for the last experiment shown at the bottom of panel B [shift-down at 12 hpi])
were obtained in parallel and served as the controls for these experiments.
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levels obtained from cultures maintained at 40°C. These data
show that reversibility of the ts arrest is also dependent on de
novo DNA synthesis and suggest that the DNA crystalloids
that accumulate at 40°C cannot provide viral genomes for
encapsidation into fresh virions.
Morphology, protein composition, and specific infectivity of
viral particles purified from nonpermissive tsI6-12 infections.
IMVs produced during wt infections can be purified by ultra-
centrifugation through a 36% sucrose cushion followed by
banding on a 25 to 40% sucrose gradient. We attempted to
apply the same protocol to the purification of viral particles
from cells infected with tsI6-12 at the nonpermissive temper-
ature. In the tsI6-12 sample, a light-scattering band was ob-
served at a position slightly above that seen with the wt sample
(Fig. 8A). Fractions were collected from each gradient, and
those containing the highest optical density were assayed for
protein content and composition, infectivity (viral titer), and
ultrastructural morphology. Protein concentrations were de-
termined on fractions solubilized with mild detergent to ensure
complete dissociation of viral particles; the peak tsI6-12 frac-
tions contained one-third to one-half of the total protein ob-
tained from the peak wt fractions. To quantitate the infectivity
FIG. 8. Purification and characterization of wt and tsI6-12 particles produced during 40°C infections. (A) Sucrose gradient purification. Cells
were infected with wt virus or tsI6-12 (MOI of 2) for 24 h at 40°C. Virus particles were purified from cytoplasmic extracts by sedimentation through
a 36% sucrose cushion followed by banding on a 25 to 40% sucrose gradient. The arrow points to light-scattering bands containing viral particles.
(B) Transmission electron microscopy of wt and tsI6-12 particles. Peak fractions from the sucrose gradients were retrieved, concentrated, and
subjected to analysis by conventional transmission electron microscopy. (C) Comparison of the overall protein profiles of the wt and tsI6-12
particles. Gradient fractions 10 to 15 corresponded to the light-scattering bands and contained the peak protein content. Equal volumes of the
indicated fractions were resolved by SDS-PAGE and developed by silver staining. Closed arrows (left side of panel) indicate proteolytically
processed viral core proteins, and open arrows (right side of panel) point to the uncleaved precursor form of these core proteins. Protein standards
are shown at the left, with their molecular masses indicated in kilodaltons. (D) Detection of selected viral proteins in purified wt and tsI6-12
particles. Samples of purified wt and tsI6-12 particles containing equal amounts of protein, as measured by a Bradford assay, were resolved by
SDS-PAGE and transferred to nitrocellulose membranes. Filters were probed with antisera specific for the L1, H5, I7, F18, L4, and I1 proteins.
Immunoreactive proteins were visualized by chemiluminescence after development with appropriate secondary antisera.
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of the samples, monolayers were infected at 32°C with an
equivalent number of particles (normalized by protein con-
tent) from the ts or wt peak fractions and plaques were counted
after 48 h. The particle/PFU ratio of the tsI6-12 preparations
was 80-fold higher than that of the wt preparations. The de-
termination that the specific infectivity of tsI6-12 particles was
1.25% of that of wt particles corresponded well to our initial
demonstration that the viral yield from tsI6-12-infected cul-
tures was 2 logs lower than that obtained from wt-infected
cultures (Fig. 2). When we examined pooled purified prepara-
tions by conventional transmission electron microscopy, the wt
sample was shown to consist mainly of IMV whereas the
tsI6-12 sample contained deformed particles corresponding to
the half-filled and dense spherical particles observed in the
infected cells (Fig. 8B; compare with Fig. 6).
Aliquots from the gradients corresponding to the light-scat-
tering band were also resolved by SDS-PAGE and visualized
by silver staining (Fig. 8C). wt and tsI6-12 fractions were found
to have similar protein profiles once the processing status of
the structural proteins was taken into account. p4a, p4b, and
pre-L4 predominated in the fractions from the tsI6-12 gradi-
ent, whereas the cleaved products predominated in the frac-
tions obtained from the wt sample. To obtain a more refined
view of the protein composition of the two particle prepara-
tions, equivalent amounts of protein were resolved electro-
phoretically and subjected to immunoblot analysis using anti-
sera generated against multiple viral proteins (Fig. 8D). All the
proteins surveyed (L1, H5, I7, I1, F18, and L4) were present at
similar levels in the wt and tsI6-12 samples, except the L4
protein was present primarily as an uncleaved precursor in the
ts-I6 sample.
tsI6-12 particles are devoid of viral DNA. The gradient frac-
tions described above were also subjected to Southern dot blot
analysis to quantitate the amount of viral DNA encapsidated in
the purified particles (Fig. 9). In the wt sample, a characteristic
profile of DNA content was seen, with peak levels found in
fraction 12. A dramatically different result was seen for the
tsI6-12 sample: no peak of DNA was found. Background levels
of hybridization were detected for the whole range of fractions
tested. The mutant particles, therefore, appear to be devoid of
viral DNA. We conclude that at nonpermissive temperatures,
the tsI6-12 mutation leads to a failure in genome encapsida-
tion.
DISCUSSION
The vaccinia virus I6 protein first came to our attention
because of its ability to bind to the telomeric hairpins of the
viral genome with high specificity and stability; this interaction
is dependent upon the extrahelical bases that distinguish these
unusual telomeres (6). We hypothesized that this protein
would be involved in an important facet of genome metabo-
lism, either in the initiation of DNA synthesis or the encapsi-
dation of viral DNA. We chose a genetic approach to the
deciphering of the role of I6 in vivo, attempting to generate I6
alleles that would confer a conditionally lethal phenotype.
Clusters of charged residues in eight regions of the I6 ORF
were mutated to alanine, and recombinant viruses containing
these mutations at the endogenous locus were successfully
isolated and analyzed for temperature sensitivity. Our initial
screening of comparative viral replication at 32 and 40°C in-
volved two assays: (i) a plaque assay and (ii) the quantitation of
viral yield from a single, synchronous infectious cycle. The
phenotypes of vI6-4, vI6-5, vI6-6, and vI6-9 were indistinguish-
able from that of wt virus in both experiments. In contrast,
vI6-1, vI6-2, vI6-12, and vI6-13 exhibited a small plaque phe-
notype at the nonpermissive temperature. A reduction in
plaque size can reflect either a diminution in total virus pro-
duction or a specific defect in viral spread to neighboring cells.
To distinguish between the two possibilities, the amount of
total cell-associated virus produced in a single infectious cycle
was measured. vI6-1, vI6-2, and vI6-13 showed a decrease in
viral yield of 6- to 8-fold relative to that of wt virus at 32°C and
a 30- to 40-fold decrease compared to that of wt virus at 40°C.
vI6-12 exhibited the tightest ts phenotype, producing wt levels
of infectious virus at 32°C and 100-fold less virus at 40°C. This
mutant (denoted tsI6-12) was chosen for further characteriza-
tion.
We next examined several parameters of the viral life cycle
to determine which processes were impaired during nonper-
FIG. 9. Purified tsI6-12 particles are devoid of viral DNA. Equal
volumes of fractions 7 to 18 of the sucrose gradients used to purify wt
and tsI6-12 particles were spotted in duplicate onto ZetaProbe mem-
branes. Southern dot blot analysis was utilized to quantitate the levels
of viral DNA in each fraction. A digital image from a phosphorimager
is shown in the top portion of the figure; hybridization signal levels (in
arbitrary [arb.] units) were quantitated by phosphorimager analysis
and a graphical representation of the data are shown in the bottom
portion of the figure.
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missive infections with tsI6-12. No defect was observed in viral
gene expression, DNA replication, or concatemer resolution.
These data indicated that the arrest occurs at a late stage of
infection and involves either viral morphogenesis or virion
infectivity. Proteolytic processing of several major core pro-
teins known to undergo cleavage during virion maturation was
diminished, suggesting that morphogenesis was likely to be
affected by the tsI6-12 mutation. We therefore pursued a more
thorough analysis of virion morphogenesis by electron micros-
copy. tsI6-12-infected cells harvested at either 12 or 17 hpi
showed a clear and dramatic perturbation in virus assembly.
The hallmarks of the earlier stages of viral morphogenesis,
such as electron-dense virosomes, membrane crescents, and
IV, were observed. However, the normal progression of mor-
phogenesis was then blocked, since there were few, if any, IVN
or IMV. Instead, we observed several types of aberrant parti-
cles: IV containing small electron-dense foci, half-filled parti-
cles with electron-dense material distributed asymmetrically at
one pole, and spherical, electron-dense particles. In addition,
we saw large membrane-enclosed crystalloids, which were
comprised of an array of parallel filaments. Crystalloids
(thought to comprise viral DNA) have been observed previ-
ously in cells infected in the presence of RIF (14), which blocks
morphogenesis prior to IV formation, and in the absence of
functional A32 or I7 proteins (4, 9). Whereas the typical crys-
talloids seen in the presence of RIF have a fairly uniform,
oblong appearance, the crystalloids seen in tsI6-12-infected
cells were much larger and more irregular, as if several crys-
talloids with different orientations had adhered together. As
has been documented for wt infections performed in the pres-
ence of RIF (data not shown) and for nonpermissive ts16
infections (9), the crystalloids we observe during nonpermis-
sive tsI6-12 infections appear to be surrounded by membranes.
The presence of membranes surrounding the crystalloids is
particularly interesting in the light of recent evidence that
DNA synthesis occurs in membrane-delimited regions of the
cytoplasm (34).
Consistent with the observed defect in virion morphogene-
sis, temperature-shift experiments demonstrated that the exe-
cution point of I6 during a tsI6-12 infection occurs during very
late stages of the virus life cycle. These experiments also dem-
onstrated that de novo morphogenesis is required to reverse
the ts arrest, since no recovery of virus production was seen
when cultures were shifted down to 32°C at 12 hpi in the
presence of RIF. Apparently the aberrant particles that accu-
mulate at 40°C are dead-end products rather than functional
intermediates, since they are unable to mature into IMV upon
a shift to the permissive temperature. A restoration of virus
production was also not seen when cultures were shifted to the
permissive temperature in the presence of araC, indicating that
de novo DNA synthesis is also needed for reversal of the ts
phenotype. The crystalloids that accumulated in tsI6-12-in-
fected cells must have represented viral DNA that had as-
sumed an aggregated, unusable conformation. In contrast, the
crystalloids that accumulated in the presence of RIF appeared
to be depots of functional DNA, since the RIF-induced arrest
to virus production can be reversed at 12 hpi in the presence of
araC (data not shown).
Our electron microscopic analysis indicated that in nonper-
missive tsI6-12 infections, morphogenesis arrested at a point
beyond the formation of IVs. We were interested in purifying
the aberrant particles that seemed to accumulate to further
analyze their structure and function. Cytoplasmic extracts from
nonpermissively infected cultures were therefore sedimented
through a sucrose cushion, and the pellet was applied to a
sucrose gradient. A light-scattering band was observed at a
position slightly above that seen with the wt sample. The con-
tents of the band were retrieved and concentrated; electron
microscopic analysis indicated that the preparation consisted
almost exclusively of the half-filled and electron-dense spher-
ical particles described above. The wt sample, as expected,
contained almost exclusively IMV; the specific infectivity (in
PFU per microgram) of the tsI6-12 particles was 1.25% of that
of wt virus. The overall protein profile of the tsI6-12 particles
appeared similar to that of the wt IMV, with the exception that
precursor, rather than processed, forms of such core proteins
as 4a, 4b and L4 were seen. More specifically, the I7, I1, H5,
L1, L4, and F18 proteins were found at similar levels in the two
preparations, although L4 was primarily unprocessed in the
tsI6-12 particles.
The most dramatic characteristic of the tsI6-12 particles was
the absence of any detectable viral DNA. We conclude that the
primary defect in nonpermissive tsI6-12 infections is the inabil-
ity of the developing virions to package viral DNA. This en-
capsidation defect is certainly consistent with the two-log re-
duction in infectious virus production that we observed.
However, the fact that tsI6-12 formed small but detectable
plaques at 40°C is puzzling. These plaques may have arisen due
to limited spread of the residual number of infectious particles
that were produced. Alternatively, the plaques may reflect the
delivery of aberrant particles into neighboring cells, with con-
comitant induction of cytopathic effect due to viral entry
and/or delivery of viral proteins. In support of the latter hy-
pothesis, we have infected monolayers with the purified, aber-
rant particles produced at 40°C from tsI6-12-infected cells and
shown that the encapsidated F18 protein is in fact delivered
into these cells (data not shown) (24).
The phenotype of tsI6-12 at nonpermissive temperature is
remarkably similar to that seen when expression of the A32
protein is repressed (vA32i-IPTG) (4). A32 is a putative
ATPase with limited sequence homology to the products of
gene I of filamentous, single-stranded DNA bacteriophages
and to the IVa2 gene of adenovirus, both shown to be ATPases
involved in DNA packaging (22). In cells infected nonpermis-
sively with vA32i (-IPTG), morphogenesis arrests after IV for-
mation; crystalloids and spherical electron-dense particles
were observed, although the half-filled particles described here
were not seen. The purified, electron-dense particles had a
protein profile similar to that of wt IMV, but the viral DNA
content was only 18% of that of wt IMV.
Thus, A32 and I6 are now the two vaccinia virus proteins
implicated directly in the process of DNA encapsidation. In-
terestingly, the DNA-deficient particles obtained in both cases
still contain wt levels of the F18 protein. F18 is an abundant,
basic, 11-kDa phosphoprotein that has been described as part
of the nucleoprotein complex and is the most abundant com-
ponent of the virion core (19, 20). Repression of F18 leads to
a block in morphogenesis at the stage of IVN formation (42).
The observation that F18 enters viral particles at wt levels in
the absence of DNA encapsidation certainly argues against a
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conventional role for F18 as an integral component of the
nucleoprotein complex. It remains possible, however, that F18
might coat the DNA after entry during the process of core
formation and virion maturation. Given the finding that the
particles purified from tsI6-12-infected cells lack viral DNA, it
was initially surprising that they formed a light-scattering band
with a density that was only slightly different from that of wt
particles. However, it was reported some years ago that the
viral DNA accounts for only 3% of the mass of the virion (43).
The complex process of viral DNA packaging has been best
studied in bacteriophage models such as 	29, 
, T4, and P22
(reviewed in references 5, 11, and 13). DNA is packaged into
the procapsid head, a spherical intermediate that transforms
into the mature capsid following DNA encapsidation. DNA
entry occurs at a single opening termed the connector or por-
tal. In the case of 
 phage, the terminase binds to DNA cos
sites found at the termini of concatemeric intermediates and
then associates with docking proteins located on the procapsid
connector. The ATPase activity of the terminase provides en-
ergy needed for DNA translocation through the channel. Once
an internal cos site marking the boundary of the monomeric
genome is reached, the terminase cleaves the concatemer so
that only one copy of the genome is packaged.
DNA encapsidation in animal viruses is less well understood,
although there are many parallels between herpes simplex vi-
rus type 1 (HSV-1) and adenovirus packaging and the bacte-
riophage pathway. Namely, key proteins binds to specific se-
quences in the DNA and then localize to a site in the procapsid
as a consequence of DNA binding and prior to DNA entry.
Seven proteins in HSV-1 have been implicated in DNA pack-
aging: UL6, UL15, UL17, UL25, UL28, UL32, and UL33 (re-
viewed in reference 17). UL28 recognizes and binds to termi-
nal DNA sequences (pac sites) (1), which are important for
packaging and cleavage of concatemeric intermediates into
monomeric genomes. UL28 binds UL15, a putative ATPase,
and the heterodimer associates with the procapsid possibly by
direct interaction with the UL6 portal protein (23, 33, 39, 40).
The current hypothesis proposes that the UL28/UL15 het-
erodimer acts as the terminase, with UL28 binding to specific
sites on the viral DNA and UL15 providing the energy for
genome resolution and translocation.
It is tempting to speculate whether a related packaging
mechanism is utilized by vaccinia virus. Unlike that of HSV-1,
resolution of the vaccinia virus concatemeric intermediates is
uncoupled from DNA encapsidation, although it is a prereq-
uisite step. In the absence of the Holliday junction resolvase
A22, branched and concatemeric genomes accumulate and a
morphogenesis defect similar to that observed with vA32-
IPTG and tsI6-12 is seen (12). Apparently, only monomeric
forms of the genome are packaged and concatemers are ex-
cluded; a defect in resolution indirectly results in a DNA pack-
aging defect. However, concatemer resolution is not impaired
in the absence of functional A32 or I6 (conditions under which
genome encapsidation is abolished). We propose the following
working model for vaccinia virus genome encapsidation. We
hypothesize that I6 binds to the telomeres of monomeric ge-
nomes and then interacts with A32 found on the surface of IV.
We propose that once binding by I6 occurs, the ATPase activ-
ity of A32 becomes activated and provides the energy needed
for DNA translocation into the maturing virion. DNA trans-
location may take place through a pore or an unsealed gap in
the immature virion that closes once the translocation process
is complete. Alternatively, the entry of the genome may lead to
invagination of the IV membrane such that an internal mem-
brane surrounds the core of IMV. With the identification of
the I6 protein as an essential component of the encapsidation
machinery, testing and refinement of this working model of
poxvirus DNA encapsidation should prove to be feasible and
intriguing.
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